Findings from cell culture and animal models showed that ERβ signaling is induced by infiltrating T cells and consequently increased MET expression directly by binding to MET gene promoter or through modulation of interleukin-1 expression in bladder cancer, leading to invasion and metastasis. The gene discussed is ESR2; the disease is urinary bladder carcinoma.